Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03333343 |
Title | Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ITA | DEU | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Novartis Investigative Site | Essen | 45147 | Germany | Details | ||
Novartis Investigative Site | Koeln | 50937 | Germany | Details | ||
Novartis Investigative Site | Shatin New Territories | Hong Kong | Details | |||
Novartis Investigative Site | Ancona | AN | 60126 | Italy | Details | |
Novartis Investigative Site | Milano | MI | 20162 | Italy | Details | |
Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
Novartis Investigative Site | Singapore | 119228 | Singapore | Details | ||
Novartis Investigative Site | Singapore | 168583 | Singapore | Details | ||
Novartis Investigative Site | Tainan | 70403 | Taiwan | Details | ||
Novartis Investigative Site | Taipei | 10002 | Taiwan | Details |